Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 (Q42948846)

https://api.crossref.org/works/10.1038/PCAN.2010.25

11 November 2017

title

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 (English)

1 reference

15 June 2024

0 references

7

1 reference

11 November 2017

5

J. L. Persson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

author name string

J L Persson

4

1 reference

11 November 2017

A. Dahlman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

A. Edsjö

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

C. Halldén

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

J. L. Persson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

S. W. Fine

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

W. Gerald

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

A. Bjartell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

15 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20680031

15 June 2024

publication date

3 August 2010

1 reference

full work available at URL

11 November 2017

https://lup.lub.lu.se/search/files/5131020/1692027.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20680031

https://www.nature.com/articles/pcan201025.pdf

15 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/PCAN.2010.25

https://www.nature.com/articles/pcan201025

15 June 2024

1 reference

https://api.crossref.org/works/10.1038/PCAN.2010.25

Prostate Cancer and Prostatic Diseases

15 June 2024

published in

1 reference

11 November 2017

volume

13

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

369-375

1 reference

11 November 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Three predominant proteins secreted by the human prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Prognostic significance of beta-microseminoprotein mRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Mutation analysis of the MSMB gene in familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

beta-Microseminoprotein binds CRISP-3 in human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Characterization and localization of cysteine-rich secretory protein 3 (CRISP-3) in the human male reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Cellular expression of beta-microseminoprotein (beta-MSP) mRNA and its protein in untreated prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Increased intratumoral expression of prostate secretory protein of 94 amino acids predicts for worse disease recurrence and progression after radical prostatectomy in patients with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.25

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target

31 March 2020

https://api.crossref.org/works/10.1038/PCAN.2010.25

4

1 reference

15 June 2024

Identifiers

DOI

10.1038/PCAN.2010.25

1 reference

Dimensions Publication ID

11 November 2017

1032057498

0 references

1 reference